International (Europe)

Vaccine Research Center Opened in Belgium

Published in Hepatitis Weekly, May 6th, 1996

SmithKline Beecham opened a vaccine research and development complex, holding out hopes to parents that their children could soon benefit from a six-in-one vaccination.

SmithKline Beecham Biologicals executives briefing the press at the center's formal launch said the company was developing a treatment that would protect against six diseases in one and which the company considered one of its most exciting products. The six diseases are diptheria, tetanus, whooping cough, hepatitis B, haemophilus influenzae (which can produce meningitis in children), and polio.

Further research seeks to include protection against Hepatitis A. "In principle, the main...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (1996-05-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry